If the exams, tests, and procedures show that your pet can take part in the study, and you choose to enroll them, you pet will attend a total of five study visits. At the enrollment visit (Day 1), your pet will have a physical examination and blood collected for complete blood count (CBC), chemistry panel, and study purposes. Your pet will receive an intravenous dose of EARLI-001 and be monitored for two hours. At the follow-up visits (Days 4, 8, 12, and 15) your pet will have a physical examination and blood collected for complete blood count (CBC), chemistry panel, and/or study purposes.
If you wish to have your pet participate in this study, you will be responsible for bringing your pet for each study visit.
We are looking for dogs with confirmed locally advanced or metastatic cancer who have not undergone treatment within the past 30 days.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.